212 related articles for article (PubMed ID: 22706115)
1. [The role of ceramides in selected brain pathologies: ischemia/hypoxia, Alzheimer disease].
Car H; Zendzian-Piotrowska M; Fiedorowicz A; Prokopiuk S; Sadowska A; Kurek K
Postepy Hig Med Dosw (Online); 2012 May; 66():295-303. PubMed ID: 22706115
[TBL] [Abstract][Full Text] [Related]
2. Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus.
Nakane M; Kubota M; Nakagomi T; Tamura A; Hisaki H; Shimasaki H; Ueta N
Neurosci Lett; 2000 Dec; 296(2-3):89-92. PubMed ID: 11108988
[TBL] [Abstract][Full Text] [Related]
3. JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction.
Yu J; Novgorodov SA; Chudakova D; Zhu H; Bielawska A; Bielawski J; Obeid LM; Kindy MS; Gudz TI
J Biol Chem; 2007 Aug; 282(35):25940-9. PubMed ID: 17609208
[TBL] [Abstract][Full Text] [Related]
4. De novo C16- and C24-ceramide generation contributes to spontaneous neutrophil apoptosis.
Seumois G; Fillet M; Gillet L; Faccinetto C; Desmet C; François C; Dewals B; Oury C; Vanderplasschen A; Lekeux P; Bureau F
J Leukoc Biol; 2007 Jun; 81(6):1477-86. PubMed ID: 17329567
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin synthase-related protein SMSr is a suppressor of ceramide-induced mitochondrial apoptosis.
Tafesse FG; Vacaru AM; Bosma EF; Hermansson M; Jain A; Hilderink A; Somerharju P; Holthuis JC
J Cell Sci; 2014 Jan; 127(Pt 2):445-54. PubMed ID: 24259670
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.
Allan D
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):603-10. PubMed ID: 10642519
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic sphingolipid signaling by ceramides in lung endothelial cells.
Medler TR; Petrusca DN; Lee PJ; Hubbard WC; Berdyshev EV; Skirball J; Kamocki K; Schuchman E; Tuder RM; Petrache I
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):639-46. PubMed ID: 18192502
[TBL] [Abstract][Full Text] [Related]
8. Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia.
Chen SD; Yin JH; Hwang CS; Tang CM; Yang DI
Free Radic Res; 2012 Aug; 46(8):940-50. PubMed ID: 22583533
[TBL] [Abstract][Full Text] [Related]
9. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
10. Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity.
Tserng KY; Griffin RL
Biochem J; 2004 Jun; 380(Pt 3):715-22. PubMed ID: 14998372
[TBL] [Abstract][Full Text] [Related]
11. Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells.
Jin J; Hou Q; Mullen TD; Zeidan YH; Bielawski J; Kraveka JM; Bielawska A; Obeid LM; Hannun YA; Hsu YT
J Biol Chem; 2008 Sep; 283(39):26509-17. PubMed ID: 18676372
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ceramide in ischemic tolerance induced by preconditioning with sublethal oxygen-glucose deprivation in primary cultured cortical neurons of rats.
Bhuiyan MI; Islam MN; Jung SY; Yoo HH; Lee YS; Jin C
Biol Pharm Bull; 2010; 33(1):11-7. PubMed ID: 20045928
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of sphingolipid metabolism in Alzheimer's disease.
He X; Huang Y; Li B; Gong CX; Schuchman EH
Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin.
Dai Q; Liu J; Chen J; Durrant D; McIntyre TM; Lee RM
Oncogene; 2004 Apr; 23(20):3650-8. PubMed ID: 15077187
[TBL] [Abstract][Full Text] [Related]
16. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.
Cutler RG; Kelly J; Storie K; Pedersen WA; Tammara A; Hatanpaa K; Troncoso JC; Mattson MP
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2070-5. PubMed ID: 14970312
[TBL] [Abstract][Full Text] [Related]
17. Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation.
Jazvinšćak Jembrek M; Hof PR; Šimić G
Oxid Med Cell Longev; 2015; 2015():346783. PubMed ID: 26090071
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
Claus RA; Dorer MJ; Bunck AC; Deigner HP
Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
20. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis.
Birbes H; El Bawab S; Hannun YA; Obeid LM
FASEB J; 2001 Dec; 15(14):2669-79. PubMed ID: 11726543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
